News

The SYNERGY trial is designed to evaluate the safety and efficacy of Synavive, a low-dose glucocorticoid with the potential for amplified immuno-inflammatory benefits, in RA patients. The company

The new platform developed by Kadimastem permits usage of human functional tissues produced industrially from pluripotent stem cells as a way to search for potential new drugs. The

Kolliphor TPGS is a water-soluble derivative of vitamin E that can directly improve the bioavailability of poorly soluble active substances. BASF Global Business Unit Pharma Ingredients & Services

Twister is a transparent device that operates by three simple steps: Insert, Twist and Inhale. Aptar Pharma Prescription Division Business Development associate director Adam M. Shain said Twister

The grant will be used to cover R&D expenses for the period March to December 2012, the company said. Pluristem chairman and CEO Zami Aberman said, "This grant

As a part of the agreement, MannKind is eligible to receive upfront and milestone payments of approximately $130m, linked to the development, approval and commercialization of products, from

Under the agreement, Mylan is allowed to sell generic versions of 50mg, 150mg, and 250mg Nuvigil in June 2016, or earlier under certain undisclosed circumstances. Teva accepts that

Reach2HD is a double blind placebo controlled study enrolling 100 patients with early to mid-stage Huntington Disease. The six month study aims to demonstrate cognitive improvements as already

The company begins the shipment of the product. Mayne Pharma’s Doryx 150mg product is marketed by Warner Chilcott and is a tetracycline-class antimicrobial. The launch follows the favorable